Latest filing published 19 Apr 2017 for Q BioMed Inc., €30k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Alan P. Lindsay: trading record in brief
Alan P. Lindsay has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Uranium Energy Corp, MIV Therapeutics Inc and Q BioMed Inc. Between 30 May 2006 and 11 April 2017, the trades on record add up to 33 filings.
The open-market side counts 1 purchase for €52k alongside 22 sales for €175k. Netting one side against the other leaves €123k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 10 share grants. So far in 2017, the count stands at no purchases and 4 sales.
The newest entry dates from 19 April 2017: an open-market sale of €14k, in Q BioMed Inc. The latest purchase dates back some time: it was published 6,208 days ago, on 9 November 2009. Typically, a trade is published a median of 19 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alan P. Lindsay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$6.5444.7% of flowCommon StockSEC:0001589728-17-000004:0
- 2,500 shares@ US$6.1621.2% of flowCommon StockSEC:0001589728-17-000004:1
- 2,400 shares@ US$5.8819.5% of flowCommon StockSEC:0001589728-17-000004:2
- 2,000 shares@ US$5.2514.6% of flowCommon StockSEC:0001589728-17-000004:3
- 18,519 shares@ US$1.35Common StockSEC:0001183740-15-000211:0
- 22,099 shares@ US$1.81Common StockSEC:0001183740-14-000027:0
- 25,714 shares@ US$0.35Common StockSEC:0001183740-10-000053:0
- 391,202 shares@ US$0.20Common StockSEC:0001183740-09-000504:0Canonical exit: 13 Jan 2010 (T+90)
- 101,267 shares0Common StockSEC:0001001277-08-000152:0
- 1,506,181 shares@ US$0.20Common StockSEC:0001001277-08-000145:0
- 158,669 shares0Common StockSEC:0001001277-08-000142:0
- 76,358 shares0Common StockSEC:0001001277-08-000107:0
- 54,185 shares@ US$0.55commonSEC:0001303600-08-000003:0
- 39,392 shares@ US$0.40commonSEC:0001303600-07-000008:0
- 30,576 shares@ US$0.40commonSEC:0001303600-07-000008:1
- 2,000 shares@ US$4.63COMMON STOCKSEC:0001183740-07-000035:3
- 3,000 shares@ US$4.52COMMON STOCKSEC:0001183740-07-000035:0
- 3,000 shares@ US$4.55COMMON STOCKSEC:0001183740-07-000035:1
- 3,000 shares@ US$4.60COMMON STOCKSEC:0001183740-07-000035:2
- 1,100 shares@ US$3.36Common StockSEC:0001092306-06-000409:0
- 1,400 shares@ US$3.36Common StockSEC:0001092306-06-000409:1
- 2,000 shares@ US$3.40Common StockSEC:0001092306-06-000409:2
- 2,500 shares@ US$3.42Common StockSEC:0001092306-06-000409:3
- 4,000 shares@ US$3.45Common StockSEC:0001092306-06-000409:4
- 1,000 shares@ US$3.40Common StockSEC:0001092306-06-000409:5
25 of 26 declarations